Business

National Research Corporation Announces 2019 Fourth Quarter and Year-End Results

LINCOLN, Neb., Feb. 11, 2020 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced 2019 fourth quarter and year-end financial

articleNrc HealthFebruary 11, 20203/company/national-research-corp/news/national-research-corporation-announces-2019-fourth-quarter-and-year-end-results
National Research Corporation Announces 2019 Fourth Quarter and Year-End Results

About this update from Nrc Health

[{"type":"text","content":"LINCOLN, Neb., Feb. 11, 2020 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced 2019 fourth quarter and year-end financial results.\n Fourth quarter 2019 compared to the fourth quarter 2018: Total Contract Value increased to $144.8 million, up 10%Revenue increased 6% to $32.6 millionOperating Income increased 27% to $12.0 million 2019 calendar year results compared to 2018: Net New Sales of $27.7 million, up 18%Revenue increased 7% to $128.0 millionOperating Income increased 22% to $43.0 millionVoice of the Customer platform contract value surpassed $100 million, a 31% increase Commenting on recent performance, Michael D. Hays, chief executive officer of National Research Corporation, said, “Our performance throughout the year reflects strong gains across the continuum of care where we witnessed growth in new customer acquisition and increased spend from existing customers which further validated increasing momentum for NRC’s industry-leading Voice of the Customer platform. Revenue for the quarter ended December 31, 2019, was $32.6 million, compared to $30.6 million for the same quarter in 2018. Net income for the quarter ended December 31, 2019, was $8.7 million, compared to $7.8 million for the quarter ended December 31, 2018. Diluted earnings per share increased to $0.34 for the common stock (formerly Class A) for the quarter ended December 31, 2019, from diluted earnings per share of $0.30 for the quarter ended December 31, 2018. Regarding the Company’s financial performance, Kevin Karas, chief financial officer of National Research Corporation, said, “The significant growth in contract value, combined with the continued shift towards our higher margin VoC platform solutions, translated into strong financial performance with record revenue and operating income in the fourth quarter 2019. On a year-to-date basis, we increased net new sales by 18% over 2018 driven by the compelling value proposition of our VoC platform solutions.” A listen-only simulcast of National Research Corporation’s 2019 fourth quarter conference call will be available online at http://edge.media-server.com/mmc/p/c88rjqy6 on February 12, 2020, beginning at 11:00 a.m. Eastern time. The online replay will follow approximately one hour later and continue for 30 days. For more than 38 years, National Research Corporation has been ...

More updates from Nrc Health